title: Pharmacokinetic interaction studies of fenugreek with CYP3A  substrates cyclosporine and carbamazepine.
abstract: The present study investigated the effect of fenugreek seed powder on disposition of CYP3A substrates, cyclosporine and carbamazepine. Rabbits were treated with fenugreek seed powder (300 mg/kg p.o.) for 8 days and on 8th day the single dose of cyclosporine (30 mg/kg, p.o.) and carbamazepine (40 mg/kg, p.o.) were administered to the corresponding group after 1 h of fenugreek administration. Blood samples were drawn at several time points and analyzed by using UPLC-MS (cyclosporine) and HPLC (carbamazepine). Pharmacokinetic parameters were calculated by using PK Solver. The present investigation reveals that there was no statistically significant difference between pre- and post-treated pharmacokinetic parameters such as AUC(o-t), AUC(o-∞), C(max), T(max), T(1/2), K(el), MRT(o-∞) , V(z/F), and Cl/F for cyclosporine and carbamazepine. Two tailed "P" values for all these pharmacokinetic parameters were more than 0.05, indicating insignificant impact of fenugreek treatment on the disposition of cyclosporine and carbamazepine. Further, fenugreek may also not have any significant effect on the functionality of P-glycoprotein as cyclosporine is a substrate to P-glycoprotein. The outcomes of present study suggested that fenugreek may not likely to interfere cyclosporine and carbamazepine pharmacokinetics, when co-administered with these drugs.
authors.forename: Fahad I
authors.initials: FI
authors.lastname: Al-Jenoobi
authors.forename: Mohd Aftab
authors.initials: MA
authors.lastname: Alam
authors.forename: Khalid M
authors.initials: KM
authors.lastname: Alkharfy
authors.forename: Saleh A
authors.initials: SA
authors.lastname: Al-Suwayeh
authors.forename: Hesham M
authors.initials: HM
authors.lastname: Korashy
authors.forename: Abdullah M
authors.initials: AM
authors.lastname: Al-Mohizea
authors.forename: Muzaffar
authors.initials: M
authors.lastname: Iqbal
authors.forename: Abdul
authors.initials: A
authors.lastname: Ahad
authors.forename: Mohammad
authors.initials: M
authors.lastname: Raish
mesh_terms: D000818:Animals; D002220:Carbamazepine / Q000493:pharmacokinetics*; D016572:Cyclosporine / Q000493:pharmacokinetics*; D051544:Cytochrome P-450 CYP3A / Q000378:metabolism*; D005260:Female; D041743:Herb-Drug Interactions; D008297:Male; D011817:Rabbits; D013379:Substrate Specificity; D029910:Trigonella
chemical_list: D002220:Carbamazepine; D016572:Cyclosporine; D051544:Cytochrome P-450 CYP3A
references.citation: Evid Based Complement Alternat Med. 2005 Dec;2(4):475-9
references.pmid: 16322804
references.citation: Clin Pharmacol Ther. 2000 Dec;68(6):605-12
references.pmid: 11180020
references.citation: Am J Chin Med. 2006;34(5):845-55
references.pmid: 17080549
references.citation: J Pak Med Assoc. 2011 Jul;61(7):683-7
references.pmid: 22204246
references.citation: Indian J Physiol Pharmacol. 1998 Oct;42(4):527-32
references.pmid: 10874355
references.citation: Evid Based Complement Alternat Med. 2010 Dec;7(4):419-24
references.pmid: 18955344
references.citation: Pharmacotherapy. 2001 Apr;21(4):509-12
references.pmid: 11310527
references.citation: Biol Pharm Bull. 1999 May;22(5):527-31
references.pmid: 10375176
references.citation: Transplantation. 2001 Jan 27;71(2):239-41
references.pmid: 11213066
references.citation: Phytother Res. 2009 May;23(5):603-7
references.pmid: 19173278
references.citation: Clin Pharmacokinet. 1993 Jun;24(6):472-95
references.pmid: 8513650
references.citation: Clin Pharmacokinet. 2000 Jan;38(1):41-57
references.pmid: 10668858
references.citation: Food Chem Toxicol. 2013 Jan;51:343-9
references.pmid: 23104244
references.citation: Ther Drug Monit. 2008 Dec;30(6):689-99
references.pmid: 18978522
references.citation: Biochem Pharmacol. 1994 Jun 1;47(11):1969-79
references.pmid: 8010982
references.citation: Curr Drug Metab. 2008 May;9(4):310-22
references.pmid: 18473749
references.citation: Eur J Clin Nutr. 1988 Jan;42(1):51-4
references.pmid: 3286242
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7500-2
references.pmid: 10852961
references.citation: Rev Med Chil. 2001 Jul;129(7):789-90
references.pmid: 11552449
references.citation: Clin Pharmacol Ther. 2004 Sep;76(3):192-200
references.pmid: 15371980
references.citation: Food Chem. 2013 Jan 15;136(2):450-7
references.pmid: 23122083
references.citation: Br J Clin Pharmacol. 2001 Apr;51(4):345-9
references.pmid: 11318771
references.citation: Biol Pharm Bull. 2002 Apr;25(4):532-5
references.pmid: 11995940
references.citation: Phytother Res. 2009 Nov;23(11):1553-8
references.pmid: 19370549
references.citation: ScientificWorldJournal. 2012;2012:859892
references.pmid: 23319888
references.citation: Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):129-35
references.pmid: 11554427
references.citation: Am J Kidney Dis. 2001 Nov;38(5):1105-7
references.pmid: 11684566
references.citation: Plant Foods Hum Nutr. 1999;53(4):359-65
references.pmid: 10540988
references.citation: Ann Pharmacother. 2000 Sep;34(9):1013-6
references.pmid: 10981246
references.citation: Fundam Clin Pharmacol. 2005 Feb;19(1):1-16
references.pmid: 15660956
references.citation: Drugs. 2005;65(9):1239-82
references.pmid: 15916450
references.citation: Curr Med Chem. 2012;19(21):3523-31
references.pmid: 22680628